Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Pfizer Inc. (PFE) had Normalized Income after Taxes of $2.71B for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$14.45B |
|
$2.69B |
|
$3.55B |
|
$10.90B |
|
$10.42B |
|
$4.03B |
|
$-861.00M |
|
$3.17B |
|
$3.17B |
|
$2.71B |
|
$2.71B |
|
$2.70B |
|
|
Normalized Income after Taxes |
$2.71B |
$4.03B |
|
$5.64B |
|
5.69B |
|
5.73B |
|
$0.47 |
|
$0.47 |
|
| Balance Sheet Financials | |
$42.82B |
|
$19.40B |
|
$164.79B |
|
$207.62B |
|
$34.35B |
|
$60.56B |
|
$82.87B |
|
$117.21B |
|
$90.40B |
|
$-33.56B |
|
$90.40B |
|
5.70B |
|
| Cash Flow Statement Financials | |
$2.62B |
|
$785.00M |
|
$-2.86B |
|
$1.20B |
|
$1.76B |
|
$563.00M |
|
$272.00M |
|
$-2.44B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.25 |
|
-- |
|
-- |
|
0.40 |
|
0.71 |
|
75.45% |
|
27.90% |
|
27.90% |
|
-- |
|
21.94% |
|
18.59% |
|
$2.18B |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
0.33 |
|
1.15 |
|
78.38 |
|
3.00% |
|
-8.07% |
|
1.30% |
|
1.79% |
|
$15.86 |
|
$0.38 |
|
$0.46 |
|